NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
 

CME Course Description

Login to view
Course Activities.




Registration for this expired conference is closed.

Title:
Conversations in Cardiology: September 23, 2017
Activity/Course #:
09.23.17CC
Cost:
Free
Release/Start Date:
Sep 23 2017
Expiration Date:
Sep 23 2017
Topics:
Cardiovascular
Target Audience:
Cardiologists and Primary Care Providers
Medium/Method:
live course
Estimated Time To Complete CME Activity:
3.5 hours
Hardware/Software Requirements:
Internet Explorer, Firefox and Safari browsers (Chrome not supported at this time)
Credit(s):
3.5 AMA PRA Category I Credit(s)
3.5 AANP Contact hour(s)
There is no registration fee for this CME live virtual conference!

September 23, 2017
Broadcast Live from Ft. Lauderdale, FL
Start Time: 10:00 am EST

Program Summary:

Join us for the Association of Black Cardiologists' and the National Association for Continuing Education's Conversations in Cardiology virtual live conference. Utilizing an interactive, moderator led format, this program will help you hone your skills in the diagnosis and management of patients you are likely encountering in your practice. You will be able to interact with the faculty in real-time to get your questions answered.

Topics and Learning Objectives

  1. Diabetes and Cardiovascular Disease: Recognize the incidence of cardiovascular disease and high-risk status in patients with diabetes, especially in certain racial/ethnic populations; Describe the public health implications of cardiovascular disease in diabetes; Discuss the burden of co-morbid cardiovascular disease including hypertension, dyslipidemia, coronary artery disease and heart failure in patients with diabetes; Implement evidence based treatment of patients with diabetes and cardiovascular disease.
  2. Dyslipidemia: Review current recommendations for the use of non-statin therapies in the management of dyslipidemia; Explain the role of anti-PCSK9 monoclonal antibody therapy in LDL-C reduction to achieve cardiovascular risk reduction; Describe the findings from recent trials of dyslipidemia treatments on cardiovascular outcomes; Integrate new data into treatment strategies for further improving cardiovascular outcomes in the highest risk patients.
  3. Hot Topics in Heart Failure: Discuss current guidelines in the management of HFpEF; Understand the role of newly approved medical therapy for patients with HFrEF; Discuss challenges in the use of medical device therapy in the management of HF.    
 Agenda*
10:00-10:10 AM
 

Welcome Remarks by Moderator 
Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA 


10:10-11:40
 

Type 2 Diabetes and Cardiovascular Disease: Decreasing the Risk

10:10 - 10:40
Part I: Cardiovascular Disease and Diabetes: The Increasing Disease Burden in the US   
Mark Stolar, MD

10:40 - 11:10
Part II: Co-morbid Cardiovascular Disease in Patients with Diabetes: Hypertension, Dyslipidemia, Coronary Artery Disease, and Heart Failure
Alanna A. Morris, MD

11:10 - 11:40
Part III: Treatment of Cardiovascular Disease in Patients with Diabetes: Prevention and Intervention
Robert J. Chilton, DO, FACC
11:40-12:40 PM   Making Sense of the Evolving Data to Lower Cardiovascular Risk: Integrating PCSK9 Therapy into Practice
Seth Baum, MD, 
FACC, FACPM, FAHA, FNLA, FASPC 
12:40-1:15

Break

1:15-2:15
 

Hot Topics in Congestive Heart Failure:
Addressing Controversies and Challenges You Face in Clinical Practice
Alanna A. Morris, MD   

2:15-2:20

Closing Remarks
Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA

* Subject to Change

Faculty
Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC
President, American Society for Preventive Cardiology
Clinical Affiliate Professor of
Biomedical Science Florida Atlantic University,
Founder, Excel Medical Clinical Trials
Boca Raton, FL

Robert J. Chilton, MD,FACC, FAHA
Professor of Medicine
Department of Medicine
Division of Cardiology
The University of Texas
Health Science Center at San Antonio
San Antonio, Texas

Alanna A. Morris,MD, MSc, FHFSA
Assistant Professor of Medicine
Division of Cardiology
Emory University School of Medicine
Atlanta, GA

Mark Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL

Moderator
Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA

Planning Committee
Sheila Lucas, CMEP
Activity Director
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Gregg Sherman, MD
Course Director
Chief Medical Officer
National Association for Continuing Education
Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 3.5 contact hours of continuing education (which includes pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Commercial Support
This educational activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.